Vivo Capital plans to acquire Dutscher, a leading European distributor of laboratory supplies, marking its first investment in Europe as part of an expansion strategy in the healthcare sector.
Target Information
Dutscher, founded in 1982 and headquartered in Brumath, near Strasbourg, is a leading European distributor of laboratory consumables and equipment for research and development. The company achieved a revenue exceeding €400 million in 2025, showcasing an average organic growth rate of 7% per year. With over 1,100 employees, Dutscher has established itself as a primary pan-European platform in its sector, generating more than 50% of its revenue outside of France. The company's extensive catalogue boasts over one million stock-keeping units (SKUs) and caters to more than 25,000 customers.
Under LBO France’s ownership, which began in 2020, Dutscher has fortified its European positioning through 13 acquisitions across various countries, including France, the UK, Ireland, Scandinavia, and the Baltic States. This strategic expansion has been bolstered by significant investments, including the establishment of three new warehouses in France, the UK, and Spain, enhancing the Group’s leadership in the European market.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in France
The laboratory supplies industry in France is a crucial component of the broader healthcare and life sciences sector. It serves a range of markets, including biotechnology, pharmaceuticals, and clinical resear
Similar Deals
SK Capital Partners → LISI Group's Medical division
2025
Asker Healthcare Group → Finmed SAS
2025
Vivo Capital
invested in
Dutscher
in 2026
in a Buyout deal
Disclosed details
Revenue: $400M